20 Followers on Owler
Lyell
is a California-based clinical-stage biotechnology company that develops novel cell therapies for the treatment of cancer... Read moreLyell
is a California-based clinical-stage biotechnology company that develops novel cell therapies for the treatment of cancer... Read more
Looking for similar companies to Lyell?
Lyell Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$48.5M
Lyell's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 8B. Over the last four quarters, Lyell's revenue has grown by 800%. Specifically, in Q2 2023's revenue was $ < 1M; in Q1 2023, it was $ < 1M; in Q4 2022, it was $48.4M; in Q3 2022, Lyell's revenue was $ < 1M.
Lyell News
Lyell Press Releases
Lyell Headquarters
Lyell Summary
ABOUT
Overview
Lyell is a California-based clinical-stage biotechnology company that develops novel cell therapies for the treatment of cancer. Lyell was founded in 2018. Lyell's headquarters is located in South San Francisco, California, USA 94080. Lyell's Preside...CEO
Lyell's President & CEO, Lynn Seely, currently has an approval rating of 82%. Lyell's primary competitors are Tmunity, Allogene, Instil Bio and 11 more.Website
lyell.comCompetitors
View 14 Lyell competitors here.Acquisitions
There have been no acquisitions found related to LyellFunding
View Lyell funding details.Investments
View 4 Lyell investments here.Frequently Asked Questions about Lyell
When was Lyell founded?
Lyell was founded in 2018Who is Lyell's CEO?
Lyell's CEO is Lynn SeelyHow much revenue does Lyell generate?
Lyell generates $48.5M in revenueHow much funding does Lyell have?
Lyell has historically raised $1.4B in fundingWhere is Lyell's headquarters?
Lyell's headquarters is in South San Francisco California, USA
How many employees does Lyell have?
Lyell has 270 employeesWhat sector does Lyell operate in?
Lyell is in BiotechnologyWho are Lyell's competitors?
Lyell's top competitors are Tmunity, Allogene, Instil BioWho has Lyell invested in?
Lyell's has invested in companies such as Outpace Bio, Sonoma, Sonoma